PROFACTOR PHARMA LTD
ROSLIN

Hellopages » Midlothian » Midlothian » EH25 9PP

Company number SC367055
Status Active
Incorporation Date 19 October 2009
Company Type Private Limited Company
Address ROSLIN BIOCENTRE, C/O INGENZA LTD, ROSLIN, SCOTLAND, EH25 9PP
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration forty-three events have happened. The last three records are Termination of appointment of Ian Garner as a director on 9 January 2017; Registered office address changed from C/O Dr Ian Garner 13 Lismore Avenue Edinburgh EH8 7DW to Roslin Biocentre C/O Ingenza Ltd Roslin EH25 9PP on 9 February 2017; Confirmation statement made on 19 October 2016 with updates. The most likely internet sites of PROFACTOR PHARMA LTD are www.profactorpharma.co.uk, and www.profactor-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is sixteen years and two months. The distance to to Brunstane Rail Station is 6.1 miles; to Edinburgh Rail Station is 6.3 miles; to Edinburgh Park Rail Station is 7.1 miles; to South Gyle Rail Station is 7.3 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Profactor Pharma Ltd is a Private Limited Company. The company registration number is SC367055. Profactor Pharma Ltd has been working since 19 October 2009. The present status of the company is Active. The registered address of Profactor Pharma Ltd is Roslin Biocentre C O Ingenza Ltd Roslin Scotland Eh25 9pp. . CRUSE, Richard John is a Secretary of the company. AMIN, Jaymin is a Director of the company. BROWN, David, Dr is a Director of the company. CRUSE, Richard John is a Director of the company. FOTHERINGHAM, Ian Graham, Dr is a Director of the company. PARK, John Brown Warnock is a Director of the company. Director GARNER, Ian, Dr has been resigned. Director GARNER, Ian, Dr has been resigned. Director ILYINE, Hugh Alexander has been resigned. Director SRIVASTAVA, Sunil has been resigned. Director VERNON, Bruce has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Secretary
CRUSE, Richard John
Appointed Date: 19 October 2009

Director
AMIN, Jaymin
Appointed Date: 09 November 2011
55 years old

Director
BROWN, David, Dr
Appointed Date: 19 August 2013
76 years old

Director
CRUSE, Richard John
Appointed Date: 19 October 2009
74 years old

Director
FOTHERINGHAM, Ian Graham, Dr
Appointed Date: 09 November 2011
66 years old

Director
PARK, John Brown Warnock
Appointed Date: 19 August 2013
70 years old

Resigned Directors

Director
GARNER, Ian, Dr
Resigned: 09 January 2017
Appointed Date: 28 November 2012
69 years old

Director
GARNER, Ian, Dr
Resigned: 09 November 2011
Appointed Date: 19 October 2009
69 years old

Director
ILYINE, Hugh Alexander
Resigned: 28 November 2012
Appointed Date: 19 October 2009
73 years old

Director
SRIVASTAVA, Sunil
Resigned: 16 August 2013
Appointed Date: 09 November 2011
68 years old

Director
VERNON, Bruce
Resigned: 16 August 2013
Appointed Date: 01 May 2010
64 years old

Persons With Significant Control

Ingenza Biologics Ltd
Notified on: 6 October 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

PROFACTOR PHARMA LTD Events

09 Feb 2017
Termination of appointment of Ian Garner as a director on 9 January 2017
09 Feb 2017
Registered office address changed from C/O Dr Ian Garner 13 Lismore Avenue Edinburgh EH8 7DW to Roslin Biocentre C/O Ingenza Ltd Roslin EH25 9PP on 9 February 2017
03 Nov 2016
Confirmation statement made on 19 October 2016 with updates
23 Sep 2016
Statement of capital following an allotment of shares on 15 October 2015
  • GBP 21,962

22 Sep 2016
Statement of capital following an allotment of shares on 16 September 2016
  • GBP 23,717

...
... and 33 more events
21 Jun 2011
Total exemption full accounts made up to 31 October 2010
26 Oct 2010
Annual return made up to 19 October 2010 with full list of shareholders
28 May 2010
Appointment of Mr Bruce Vernon as a director
18 May 2010
Statement of capital following an allotment of shares on 6 May 2010
  • GBP 5,000

19 Oct 2009
Incorporation